Golden Biotechnology Statistics

Total Valuation

TPEX:4132 has a market cap or net worth of TWD 3.73 billion. The enterprise value is 4.00 billion.

Market Cap	3.73B
Enterprise Value	4.00B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4132 has 162.23 million shares outstanding. The number of shares has increased by 12.93% in one year.

Current Share Class	162.23M
Shares Outstanding	162.23M
Shares Change (YoY)	+12.93%
Shares Change (QoQ)	+2.03%
Owned by Insiders (%)	14.41%
Owned by Institutions (%)	0.01%
Float	138.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	83.69
PB Ratio	19.59
P/TBV Ratio	23.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.69
EV / Sales	89.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.73

Financial Position

The company has a current ratio of 0.54, with a Debt / Equity ratio of 1.72.

Current Ratio	0.54
Quick Ratio	0.23
Debt / Equity	1.72
Debt / EBITDA	n/a
Debt / FCF	-1.37
Interest Coverage	-28.95

Financial Efficiency

Return on equity (ROE) is -146.06% and return on invested capital (ROIC) is -35.86%.

Return on Equity (ROE)	-146.06%
Return on Assets (ROA)	-33.90%
Return on Invested Capital (ROIC)	-35.86%
Return on Capital Employed (ROCE)	-117.60%
Revenue Per Employee	365,426
Profits Per Employee	-2.58M
Employee Count	122
Asset Turnover	0.08
Inventory Turnover	0.89

Taxes

In the past 12 months, TPEX:4132 has paid 118,000 in taxes.

Income Tax	118,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.25% in the last 52 weeks. The beta is 0.67, so TPEX:4132's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+42.25%
50-Day Moving Average	13.71
200-Day Moving Average	13.58
Relative Strength Index (RSI)	89.83
Average Volume (20 Days)	812,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4132 had revenue of TWD 44.58 million and -314.93 million in losses. Loss per share was -1.96.

Revenue	44.58M
Gross Profit	-11.19M
Operating Income	-305.01M
Pretax Income	-314.81M
Net Income	-314.93M
EBITDA	-280.29M
EBIT	-305.01M
Loss Per Share	-1.96

Full Income Statement

Balance Sheet

The company has 61.02 million in cash and 327.82 million in debt, giving a net cash position of -266.80 million or -1.64 per share.

Cash & Cash Equivalents	61.02M
Total Debt	327.82M
Net Cash	-266.80M
Net Cash Per Share	-1.64
Equity (Book Value)	190.50M
Book Value Per Share	1.17
Working Capital	-132.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -235.48 million and capital expenditures -3.51 million, giving a free cash flow of -238.99 million.

Operating Cash Flow	-235.48M
Capital Expenditures	-3.51M
Free Cash Flow	-238.99M
FCF Per Share	-1.47

Full Cash Flow Statement

Margins

Gross Margin	-25.10%
Operating Margin	-684.15%
Pretax Margin	-706.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:4132 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.93%
Shareholder Yield	-12.93%
Earnings Yield	-8.44%
FCF Yield	-6.41%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4132 has an Altman Z-Score of -1.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.25
Piotroski F-Score	3